Impact of relative dose intensity in gemcitabine–cisplatin chemotherapy for metastatic urothelial carcinoma

OBJECTIVES: To evaluate the impact of relative dose intensity for gemcitabine–cisplatin chemotherapy in patients with metastatic urothelial carcinoma. METHODS: We retrospectively reviewed the medical records of 18 patients with metastatic urothelial carcinoma, who received gemcitabine–cisplatin regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohei, Naoki, Sugiyama, Kyohei, Chihara, Ichiro, Muro, Yusuke, Imamura, Masaaki, Nishio, Yasunori, Yoshimura, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041858/
https://www.ncbi.nlm.nih.gov/pubmed/30013781
http://dx.doi.org/10.1177/2050312118783011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041858/
https://www.ncbi.nlm.nih.gov/pubmed/30013781
http://dx.doi.org/10.1177/2050312118783011

Ejemplares similares